nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolcapone—Panic reaction—Varenicline—nicotine dependence	0.0453	0.0522	CcSEcCtD
Tolcapone—Mental retardation—Varenicline—nicotine dependence	0.0416	0.048	CcSEcCtD
Tolcapone—Abnormal faeces—Varenicline—nicotine dependence	0.0318	0.0366	CcSEcCtD
Tolcapone—Coronary artery disease—Varenicline—nicotine dependence	0.023	0.0265	CcSEcCtD
Tolcapone—Sinus congestion—Varenicline—nicotine dependence	0.0183	0.021	CcSEcCtD
Tolcapone—Hostility—Varenicline—nicotine dependence	0.0164	0.0189	CcSEcCtD
Tolcapone—Libido increased—Varenicline—nicotine dependence	0.0149	0.0172	CcSEcCtD
Tolcapone—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0143	0.108	CbGpPWpGaD
Tolcapone—Parosmia—Varenicline—nicotine dependence	0.014	0.0161	CcSEcCtD
Tolcapone—Paranoia—Varenicline—nicotine dependence	0.0133	0.0154	CcSEcCtD
Tolcapone—Thrombosis—Varenicline—nicotine dependence	0.0128	0.0148	CcSEcCtD
Tolcapone—Delusion—Varenicline—nicotine dependence	0.0128	0.0148	CcSEcCtD
Tolcapone—Mania—Varenicline—nicotine dependence	0.0125	0.0144	CcSEcCtD
Tolcapone—Extrapyramidal disorder—Varenicline—nicotine dependence	0.0121	0.0139	CcSEcCtD
Tolcapone—Fungal infection—Varenicline—nicotine dependence	0.0118	0.0136	CcSEcCtD
Tolcapone—Nephrolithiasis—Varenicline—nicotine dependence	0.0113	0.013	CcSEcCtD
Tolcapone—Chest discomfort—Varenicline—nicotine dependence	0.0103	0.0118	CcSEcCtD
Tolcapone—Accidental injury—Varenicline—nicotine dependence	0.0103	0.0118	CcSEcCtD
Tolcapone—Viral infection—Varenicline—nicotine dependence	0.0101	0.0116	CcSEcCtD
Tolcapone—Thinking abnormal—Varenicline—nicotine dependence	0.00992	0.0114	CcSEcCtD
Tolcapone—Nocturia—Varenicline—nicotine dependence	0.00979	0.0113	CcSEcCtD
Tolcapone—Pulmonary embolism—Varenicline—nicotine dependence	0.00908	0.0105	CcSEcCtD
Tolcapone—Abnormal dreams—Varenicline—nicotine dependence	0.00898	0.0103	CcSEcCtD
Tolcapone—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.00888	0.067	CbGpPWpGaD
Tolcapone—Salivary hypersecretion—Varenicline—nicotine dependence	0.00882	0.0102	CcSEcCtD
Tolcapone—Oesophagitis—Varenicline—nicotine dependence	0.0083	0.00957	CcSEcCtD
Tolcapone—Urine output increased—Varenicline—nicotine dependence	0.00821	0.00947	CcSEcCtD
Tolcapone—Mouth ulceration—Varenicline—nicotine dependence	0.00821	0.00947	CcSEcCtD
Tolcapone—COMT—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.008	0.0604	CbGpPWpGaD
Tolcapone—Hypertonia—Varenicline—nicotine dependence	0.00796	0.00918	CcSEcCtD
Tolcapone—Mental disability—Varenicline—nicotine dependence	0.00788	0.00909	CcSEcCtD
Tolcapone—Euphoric mood—Varenicline—nicotine dependence	0.0078	0.009	CcSEcCtD
Tolcapone—Sleep disorder—Varenicline—nicotine dependence	0.00762	0.00878	CcSEcCtD
Tolcapone—COMT—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00758	0.0572	CbGpPWpGaD
Tolcapone—Diabetes mellitus—Varenicline—nicotine dependence	0.00758	0.00874	CcSEcCtD
Tolcapone—Polyuria—Varenicline—nicotine dependence	0.00751	0.00866	CcSEcCtD
Tolcapone—Eczema—Varenicline—nicotine dependence	0.00734	0.00846	CcSEcCtD
Tolcapone—Eye pain—Varenicline—nicotine dependence	0.0073	0.00842	CcSEcCtD
Tolcapone—Injury—Varenicline—nicotine dependence	0.00717	0.00827	CcSEcCtD
Tolcapone—Libido decreased—Varenicline—nicotine dependence	0.00711	0.0082	CcSEcCtD
Tolcapone—Amnesia—Varenicline—nicotine dependence	0.00702	0.00809	CcSEcCtD
Tolcapone—Atrial fibrillation—Varenicline—nicotine dependence	0.00696	0.00802	CcSEcCtD
Tolcapone—Thirst—Varenicline—nicotine dependence	0.00693	0.00799	CcSEcCtD
Tolcapone—Arthritis—Varenicline—nicotine dependence	0.00678	0.00782	CcSEcCtD
Tolcapone—Cerebrovascular accident—Varenicline—nicotine dependence	0.00673	0.00776	CcSEcCtD
Tolcapone—Lethargy—Varenicline—nicotine dependence	0.00673	0.00776	CcSEcCtD
Tolcapone—Osteoarthritis—Varenicline—nicotine dependence	0.00659	0.0076	CcSEcCtD
Tolcapone—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.00659	0.0076	CcSEcCtD
Tolcapone—COMT—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00656	0.0495	CbGpPWpGaD
Tolcapone—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00654	0.00754	CcSEcCtD
Tolcapone—Affect lability—Varenicline—nicotine dependence	0.00649	0.00748	CcSEcCtD
Tolcapone—Migraine—Varenicline—nicotine dependence	0.00649	0.00748	CcSEcCtD
Tolcapone—Psychotic disorder—Varenicline—nicotine dependence	0.00644	0.00742	CcSEcCtD
Tolcapone—Irritability—Varenicline—nicotine dependence	0.00629	0.00726	CcSEcCtD
Tolcapone—Urinary retention—Varenicline—nicotine dependence	0.00627	0.00723	CcSEcCtD
Tolcapone—Mood swings—Varenicline—nicotine dependence	0.00625	0.0072	CcSEcCtD
Tolcapone—COMT—Biological oxidations—CYP2A7—nicotine dependence	0.00619	0.0467	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—CHRNB3—nicotine dependence	0.00613	0.0463	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0061	0.046	CbGpPWpGaD
Tolcapone—Cramp muscle—Varenicline—nicotine dependence	0.00594	0.00684	CcSEcCtD
Tolcapone—COMT—Neuronal System—CHRNA6—nicotine dependence	0.00581	0.0438	CbGpPWpGaD
Tolcapone—Dysphagia—Varenicline—nicotine dependence	0.0057	0.00657	CcSEcCtD
Tolcapone—Asthma—Varenicline—nicotine dependence	0.0057	0.00657	CcSEcCtD
Tolcapone—Angina pectoris—Varenicline—nicotine dependence	0.00555	0.0064	CcSEcCtD
Tolcapone—COMT—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00548	0.0414	CbGpPWpGaD
Tolcapone—Bronchitis—Varenicline—nicotine dependence	0.00548	0.00632	CcSEcCtD
Tolcapone—Pollakiuria—Varenicline—nicotine dependence	0.00526	0.00607	CcSEcCtD
Tolcapone—COMT—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00526	0.0397	CbGpPWpGaD
Tolcapone—Erectile dysfunction—Varenicline—nicotine dependence	0.00525	0.00605	CcSEcCtD
Tolcapone—Infestation NOS—Varenicline—nicotine dependence	0.00508	0.00586	CcSEcCtD
Tolcapone—Infestation—Varenicline—nicotine dependence	0.00508	0.00586	CcSEcCtD
Tolcapone—Acute coronary syndrome—Varenicline—nicotine dependence	0.00501	0.00577	CcSEcCtD
Tolcapone—Myocardial infarction—Varenicline—nicotine dependence	0.00498	0.00574	CcSEcCtD
Tolcapone—Stomatitis—Varenicline—nicotine dependence	0.00495	0.00571	CcSEcCtD
Tolcapone—COMT—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00489	0.0369	CbGpPWpGaD
Tolcapone—Epistaxis—Varenicline—nicotine dependence	0.00479	0.00553	CcSEcCtD
Tolcapone—Sinusitis—Varenicline—nicotine dependence	0.00477	0.0055	CcSEcCtD
Tolcapone—Bradycardia—Varenicline—nicotine dependence	0.00464	0.00535	CcSEcCtD
Tolcapone—Hallucination—Varenicline—nicotine dependence	0.00454	0.00523	CcSEcCtD
Tolcapone—Hypoaesthesia—Varenicline—nicotine dependence	0.00454	0.00523	CcSEcCtD
Tolcapone—Urinary tract disorder—Varenicline—nicotine dependence	0.00451	0.00519	CcSEcCtD
Tolcapone—Oedema peripheral—Varenicline—nicotine dependence	0.00449	0.00518	CcSEcCtD
Tolcapone—Urethral disorder—Varenicline—nicotine dependence	0.00447	0.00515	CcSEcCtD
Tolcapone—Erythema multiforme—Varenicline—nicotine dependence	0.00431	0.00497	CcSEcCtD
Tolcapone—Tinnitus—Varenicline—nicotine dependence	0.00425	0.0049	CcSEcCtD
Tolcapone—COMT—Neuronal System—GABRA4—nicotine dependence	0.0042	0.0317	CbGpPWpGaD
Tolcapone—Angiopathy—Varenicline—nicotine dependence	0.00414	0.00477	CcSEcCtD
Tolcapone—Mediastinal disorder—Varenicline—nicotine dependence	0.00411	0.00474	CcSEcCtD
Tolcapone—Chills—Varenicline—nicotine dependence	0.00409	0.00472	CcSEcCtD
Tolcapone—Arrhythmia—Varenicline—nicotine dependence	0.00408	0.0047	CcSEcCtD
Tolcapone—COMT—Neuronal System—CHRNB4—nicotine dependence	0.00403	0.0304	CbGpPWpGaD
Tolcapone—Mental disorder—Varenicline—nicotine dependence	0.004	0.00461	CcSEcCtD
Tolcapone—COMT—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00398	0.0301	CbGpPWpGaD
Tolcapone—Flatulence—Varenicline—nicotine dependence	0.00391	0.00451	CcSEcCtD
Tolcapone—Dysgeusia—Varenicline—nicotine dependence	0.00389	0.00448	CcSEcCtD
Tolcapone—Muscle spasms—Varenicline—nicotine dependence	0.00382	0.0044	CcSEcCtD
Tolcapone—COMT—Neuronal System—CHRNA5—nicotine dependence	0.00374	0.0283	CbGpPWpGaD
Tolcapone—Vision blurred—Varenicline—nicotine dependence	0.00374	0.00431	CcSEcCtD
Tolcapone—Tremor—Varenicline—nicotine dependence	0.00372	0.00429	CcSEcCtD
Tolcapone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00369	0.0278	CbGpPWpGaD
Tolcapone—Ill-defined disorder—Varenicline—nicotine dependence	0.00368	0.00425	CcSEcCtD
Tolcapone—Anaemia—Varenicline—nicotine dependence	0.00367	0.00423	CcSEcCtD
Tolcapone—Agitation—Varenicline—nicotine dependence	0.00365	0.00421	CcSEcCtD
Tolcapone—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00364	0.0275	CbGpPWpGaD
Tolcapone—Malaise—Varenicline—nicotine dependence	0.00358	0.00413	CcSEcCtD
Tolcapone—Vertigo—Varenicline—nicotine dependence	0.00357	0.00411	CcSEcCtD
Tolcapone—Syncope—Varenicline—nicotine dependence	0.00356	0.00411	CcSEcCtD
Tolcapone—Palpitations—Varenicline—nicotine dependence	0.00351	0.00405	CcSEcCtD
Tolcapone—COMT—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00351	0.0265	CbGpPWpGaD
Tolcapone—Loss of consciousness—Varenicline—nicotine dependence	0.00349	0.00402	CcSEcCtD
Tolcapone—Cough—Varenicline—nicotine dependence	0.00347	0.00399	CcSEcCtD
Tolcapone—Hypertension—Varenicline—nicotine dependence	0.00343	0.00395	CcSEcCtD
Tolcapone—Myalgia—Varenicline—nicotine dependence	0.00338	0.0039	CcSEcCtD
Tolcapone—Arthralgia—Varenicline—nicotine dependence	0.00338	0.0039	CcSEcCtD
Tolcapone—Chest pain—Varenicline—nicotine dependence	0.00338	0.0039	CcSEcCtD
Tolcapone—Anxiety—Varenicline—nicotine dependence	0.00337	0.00388	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00336	0.00387	CcSEcCtD
Tolcapone—Discomfort—Varenicline—nicotine dependence	0.00334	0.00385	CcSEcCtD
Tolcapone—Dry mouth—Varenicline—nicotine dependence	0.00331	0.00381	CcSEcCtD
Tolcapone—Oedema—Varenicline—nicotine dependence	0.00324	0.00374	CcSEcCtD
Tolcapone—Infection—Varenicline—nicotine dependence	0.00322	0.00371	CcSEcCtD
Tolcapone—Shock—Varenicline—nicotine dependence	0.00319	0.00368	CcSEcCtD
Tolcapone—COMT—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00318	0.024	CbGpPWpGaD
Tolcapone—Nervous system disorder—Varenicline—nicotine dependence	0.00318	0.00366	CcSEcCtD
Tolcapone—Thrombocytopenia—Varenicline—nicotine dependence	0.00317	0.00366	CcSEcCtD
Tolcapone—Tachycardia—Varenicline—nicotine dependence	0.00316	0.00365	CcSEcCtD
Tolcapone—Skin disorder—Varenicline—nicotine dependence	0.00315	0.00363	CcSEcCtD
Tolcapone—Hyperhidrosis—Varenicline—nicotine dependence	0.00313	0.00361	CcSEcCtD
Tolcapone—Anorexia—Varenicline—nicotine dependence	0.00309	0.00356	CcSEcCtD
Tolcapone—COMT—Neuronal System—CHRNA3—nicotine dependence	0.00305	0.023	CbGpPWpGaD
Tolcapone—Hypotension—Varenicline—nicotine dependence	0.00303	0.00349	CcSEcCtD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00299	0.0226	CbGpPWpGaD
Tolcapone—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00295	0.0034	CcSEcCtD
Tolcapone—Dyspnoea—Varenicline—nicotine dependence	0.00289	0.00333	CcSEcCtD
Tolcapone—Somnolence—Varenicline—nicotine dependence	0.00288	0.00332	CcSEcCtD
Tolcapone—Dyspepsia—Varenicline—nicotine dependence	0.00285	0.00329	CcSEcCtD
Tolcapone—Decreased appetite—Varenicline—nicotine dependence	0.00282	0.00325	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Varenicline—nicotine dependence	0.0028	0.00323	CcSEcCtD
Tolcapone—Fatigue—Varenicline—nicotine dependence	0.00279	0.00322	CcSEcCtD
Tolcapone—Pain—Varenicline—nicotine dependence	0.00277	0.00319	CcSEcCtD
Tolcapone—Constipation—Varenicline—nicotine dependence	0.00277	0.00319	CcSEcCtD
Tolcapone—COMT—Neuronal System—CHRNB2—nicotine dependence	0.00269	0.0203	CbGpPWpGaD
Tolcapone—Feeling abnormal—Varenicline—nicotine dependence	0.00267	0.00308	CcSEcCtD
Tolcapone—Gastrointestinal pain—Varenicline—nicotine dependence	0.00265	0.00306	CcSEcCtD
Tolcapone—Urticaria—Varenicline—nicotine dependence	0.00257	0.00297	CcSEcCtD
Tolcapone—Body temperature increased—Varenicline—nicotine dependence	0.00256	0.00295	CcSEcCtD
Tolcapone—Abdominal pain—Varenicline—nicotine dependence	0.00256	0.00295	CcSEcCtD
Tolcapone—COMT—Neuronal System—CHRNA4—nicotine dependence	0.00244	0.0184	CbGpPWpGaD
Tolcapone—Hypersensitivity—Varenicline—nicotine dependence	0.00239	0.00275	CcSEcCtD
Tolcapone—Asthenia—Varenicline—nicotine dependence	0.00233	0.00268	CcSEcCtD
Tolcapone—Pruritus—Varenicline—nicotine dependence	0.00229	0.00264	CcSEcCtD
Tolcapone—Diarrhoea—Varenicline—nicotine dependence	0.00222	0.00256	CcSEcCtD
Tolcapone—Dizziness—Varenicline—nicotine dependence	0.00214	0.00247	CcSEcCtD
Tolcapone—Vomiting—Varenicline—nicotine dependence	0.00206	0.00238	CcSEcCtD
Tolcapone—Rash—Varenicline—nicotine dependence	0.00204	0.00236	CcSEcCtD
Tolcapone—Dermatitis—Varenicline—nicotine dependence	0.00204	0.00235	CcSEcCtD
Tolcapone—Headache—Varenicline—nicotine dependence	0.00203	0.00234	CcSEcCtD
Tolcapone—Nausea—Varenicline—nicotine dependence	0.00193	0.00222	CcSEcCtD
Tolcapone—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00168	0.0127	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.00159	0.012	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00157	0.0118	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CYP2A7—nicotine dependence	0.00106	0.00798	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP2A7—nicotine dependence	0.000272	0.00205	CbGpPWpGaD
